140 related articles for article (PubMed ID: 36744180)
1. RNA modification writers pattern in relation to tumor microenvironment and prognosis in prostate cancer.
Cheng X; Yi X
Front Genet; 2022; 13():1065424. PubMed ID: 36744180
[No Abstract] [Full Text] [Related]
2. Integrated investigation of the clinical implications and targeted landscape for RNA methylation modifications in hepatocellular carcinoma.
Zhang J; Gao J; Hu M; Xu S; Cheng C; Zheng W; Zhang J
Eur J Med Res; 2023 Jan; 28(1):46. PubMed ID: 36707911
[TBL] [Abstract][Full Text] [Related]
3. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.
Chen H; Yao J; Bao R; Dong Y; Zhang T; Du Y; Wang G; Ni D; Xun Z; Niu X; Ye Y; Li HB
Mol Cancer; 2021 Feb; 20(1):29. PubMed ID: 33557837
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk Between Four Types of RNA Modification Writers Characterizes the Tumor Immune Microenvironment Infiltration Patterns in Skin Cutaneous Melanoma.
Zhang S; Xiong Y; Zheng C; Long J; Zhou H; Zeng Z; Ouyang Y; Tang F
Front Cell Dev Biol; 2022; 10():821678. PubMed ID: 35155433
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk of RNA Adenosine Modification-Related Subtypes, Establishment of a Prognostic Model, and Immune Infiltration Characteristics in Ovarian Cancer.
Ni X; Chen C; Cui G; Ding W; Liu J
Front Immunol; 2022; 13():932876. PubMed ID: 35837397
[TBL] [Abstract][Full Text] [Related]
6. Interplay of four types of RNA modification writers revealed distinct tumor microenvironment and biological characteristics in pancreatic cancer.
Gao W; Chen D; Liu J; Zang L; Xiao T; Zhang X; Li Z; Zhu H; Yu X
Front Immunol; 2022; 13():1031184. PubMed ID: 36601127
[TBL] [Abstract][Full Text] [Related]
7. Cross talk between RNA modification writers and tumor development as a basis for guiding personalized therapy of gastric cancer.
Zhang S; Kuang G; Huang Y; Huang X; Wang W; Wang G
Hum Genomics; 2022 Apr; 16(1):14. PubMed ID: 35449086
[TBL] [Abstract][Full Text] [Related]
8. A novel scoring model based on RNA modification "writers" can predict the prognosis and guide immunotherapy in gastric cancer.
Li X; Zhou Y; Jiang Q; Huang J; Liu Z; Li Y; Guo G
Funct Integr Genomics; 2023 May; 23(2):162. PubMed ID: 37188931
[TBL] [Abstract][Full Text] [Related]
9. The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung Adenocarcinoma.
He W; Lin G; Pan C; Li W; Shen J; Liu Y; Li H; Wu D; Lin X
Front Genet; 2022; 13():761681. PubMed ID: 35154267
[No Abstract] [Full Text] [Related]
10. Cross-talk of RNA modification "writers" describes tumor stemness and microenvironment and guides personalized immunotherapy for gastric cancer.
Li Z; Zhang X; Weng W; Zhang G; Ren Q; Tian Y
Aging (Albany NY); 2023 Jun; 15(12):5445-5481. PubMed ID: 37319315
[TBL] [Abstract][Full Text] [Related]
11. Four types of RNA modification writers predict the prognosis of prostate cancer.
Fu W; Ding J; You X; Li Q; Pei X; Qin G
Andrologia; 2022 Nov; 54(10):e14552. PubMed ID: 36177790
[TBL] [Abstract][Full Text] [Related]
12. RNA modification "writer"-mediated RNA modification patterns and tumor microenvironment characteristics of cervical cancer.
Qu Y; Zhu H; Kong C; Zheng X; Wang D; Chen X; Yuan D
Clin Transl Oncol; 2022 Jul; 24(7):1413-1424. PubMed ID: 35220552
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Multi-Layer RNA Modification Patterns for the Characterization of Tumor Immune Microenvironment in Hepatocellular Carcinoma.
Xing J; Shen S; Dong Z; Hu X; Xu L; Liu X; Li Q; Zhang Y; Cui G; Yu Z
Front Cell Dev Biol; 2021; 9():761391. PubMed ID: 34858985
[No Abstract] [Full Text] [Related]
14. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
[TBL] [Abstract][Full Text] [Related]
15. RNA modification writers influence tumor microenvironment in gastric cancer and prospects of targeted drug therapy.
Song P; Zhou S; Qi X; Jiao Y; Gong Y; Zhao J; Yang H; Qian Z; Qian J; Tang L
J Bioinform Comput Biol; 2022 Apr; 20(2):2250004. PubMed ID: 35287562
[No Abstract] [Full Text] [Related]
16. N6-Methyladenosine Modification Patterns and Tumor Microenvironment Immune Characteristics Associated With Clinical Prognosis Analysis in Stomach Adenocarcinoma.
Meijing Z; Tianhang L; Biao Y
Front Cell Dev Biol; 2022; 10():913307. PubMed ID: 35813200
[No Abstract] [Full Text] [Related]
17. RNA modification writer expression profiles predict clinical outcomes and guide neoadjuvant immunotherapy in non-small cell lung cancer.
Zhou B; Bie F; Zang R; Zhang M; Song P; Liu L; Peng Y; Bai G; Zhao J; Gao S
EBioMedicine; 2022 Oct; 84():104268. PubMed ID: 36116215
[TBL] [Abstract][Full Text] [Related]
18. Characterization of m
Zhu M; Cui Y; Mo Q; Zhang J; Zhao T; Xu Y; Wu Z; Sun D; Zhang X; Li Y; You Q
Front Immunol; 2021; 12():782551. PubMed ID: 34975871
[TBL] [Abstract][Full Text] [Related]
19. The Non-N
Xu J; Gao Z; Liu K; Fan Y; Zhang Z; Xue H; Guo X; Zhang P; Deng L; Wang S; Wang H; Wang Q; Zhao R; Li G
Front Immunol; 2021; 12():809808. PubMed ID: 35154083
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Analysis of m5C Methylation Regulatory Genes and Tumor Microenvironment in Prostate Cancer.
Yu G; Bao J; Zhan M; Wang J; Li X; Gu X; Song S; Yang Q; Liu Y; Wang Z; Xu B
Front Immunol; 2022; 13():914577. PubMed ID: 35757739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
